Strategic partnership between Mission Bio and Fulgent Genetics (FLGT) will enable drug developers to leverage single-cell multi-omics for biomarker discovery, clinical research, and single-cell MRD ...
Helge Zieler, PhD, believes in the promise of biologic and genetic medicines. But for any new medicine based on nucleic acids or proteins, it’s all for nothing if the biomolecule cannot be made after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results